Source: Orthopedic Design & Technology

VYRSA: Nevro Acquires SI Joint Fusion Firm Vyrsa

Nevro paid $40 million at closing and will pay up to $35 million in additional cash or stock pending future milestones.

Read full article »

VYRSA's Competitors | VYRSA's News | VYRSA's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Co-Founder & CEO

Daniel A. Pontecorvo

CEO Approval Rating

90/100

VYRSA is a Pennsylvania-based medical technology company that designs and manufactures minimally invasive devices to treat sacroiliac joint pain for patients.